[1P-213] Zonisamide can modulate alterations in the physiological properties of T-type calcium channel CaV3.1 caused by a mutation in CACNA1G
Industry-Academia Collaboration Presentation
*Hiroyuki Morino1, Hara Naoyuki2, Matsuda Yukiko1, Hashimoto Kouichi3, Maruyama Hirofumi2, Kawakami Hideshi1 (1.Dept Epidem, RIRBM, Hiroshima Univ, Hiroshima, Japan, 2.Dept Clinical Neuroscience and Therapeutics, Hiroshima Univ, Hiroshima, Japan, 3.Dept of Neurophysiology, Hiroshima Univ, Hiroshima, Japan)